Today's Vidyya issue got started when an article in the 01 August 2000 New York Times about a new genetics company caught our attention. The company, DNA.com, has James Watson, the man credited with discovering the DNA double helix, as a director and has some very prestigious investors. Currently the company is seeking individuals interested in volunteering their DNA to further the abilities of medical science. The company isn't alone. In the last two weeks, two similar companies have gone public with IPOs.
Today's Vidyya summarizes the Times article and also provides a glossary of genetic terms (since it appears we're all going to need to speak "genetic-eez") and some recommendations from the government on how genetic information should be handled by the insurance industry.
In our ongoing effort to keep health professionals up-to-date, this issue also contains two recent warnings issued this week by the FDA for pharmaceuticals produced by Glaxo Wellcome and Abbott Laboratories.
As always, we hope you enjoy today's issue, which includes the following articles: